Overall SDG Alignment Evaluation:
The Doctor of Philosophy Program in Pharmacology is fundamentally designed to produce researchers and academics with deep expertise in drug action and development, positioning it as a crucial driver for global health. The program's core mission to create new knowledge and internationally recognized innovations makes it a powerhouse for achieving SDG 3 (Good Health and Well-being). By training experts in cutting-edge research, including molecular pharmacology and drug development, the curriculum is a key contributor to SDG 9 (Industry, Innovation, and Infrastructure) within the biomedical and pharmaceutical sectors. As an international, research-intensive doctoral program, it is a flagship for SDG 4 (Quality Education), cultivating the next generation of scientists. Through its requirement for internationally recognized research, the program fosters the global knowledge-sharing and collaboration essential for SDG 17 (Partnerships for the Goals).
SDG 3: Good Health and Well-beingAlignment Summary: This program is centrally focused on ensuring healthy lives by elucidating the mechanisms of drug action and developing new therapies. The curriculum provides an advanced, research-intensive education on molecular pharmacology, drug development, and the pharmacology of various diseases, directly contributing to the research and development of new medicines for a wide range of communicable and non-communicable diseases.
| Course Code | Course Title | Alignment Rationale |
|---|---|---|
| MD667701 | Molecular Pharmacology | Provides a deep understanding of drug-receptor interactions at the molecular level, which is foundational for rational drug design and research into new medicines (Target 3.B). |
| MD667711 | Cardiovascular Pharmacology | Directly supports efforts to combat cardiovascular diseases, a leading cause of premature mortality from non-communicable diseases (Target 3.4). |
| MD667712 | Pharmacology of Inflammation and Allergy | Contributes to health and well-being by focusing on the pharmacological basis of inflammatory and allergic diseases, leading to better treatments. |
| MD667713 | Neuro-psychopharmacology | Supports research into mental health and neurological disorders, a key component of promoting well-being (Target 3.4). |
| MD667714 | Cancer Chemotherapy | Directly supports research to combat a major non-communicable disease by focusing on the development and mechanisms of anti-cancer drugs (Target 3.4). |
| MD667733 | New Drugs and Biologics Development | This course is central to supporting research and development of new medicines, vaccines, and diagnostics, directly aligning with Target 3.B. |
SDG 4: Quality EducationAlignment Summary: As an international doctoral program, this curriculum is the epitome of quality education. It is designed to cultivate expert researchers and academics by providing advanced training in scientific research, ethics, and communication, fostering a culture of lifelong learning and contributing to the global knowledge economy in the biomedical sciences.
| Course Code | Course Title | Alignment Rationale |
|---|---|---|
| MD637701 | Biomedical Research Methodology | Provides the core research skills that define high-quality doctoral education, equipping students for high-level employment and lifelong learning in scientific research (Target 4.3 and 4.4). |
| MD66999X | Dissertation | Represents a capstone lifelong learning opportunity (Target 4.3), where students conduct original, in-depth research, acquiring superior skills for employment and innovation (Target 4.4). |
SDG 9: Industry, Innovation and InfrastructureAlignment Summary: The program is a catalyst for innovation in the pharmaceutical and biotechnology industries. By providing advanced training in cutting-edge fields like pharmacogenomics and new drug development, it enhances scientific research and upgrades the technological capabilities of sectors focused on personalized medicine and advanced healthcare solutions.
| Course Code | Course Title | Alignment Rationale |
|---|---|---|
| MD667721 | Pharmacogenomics and Precision Medicine | Drives innovation (Target 9.5) by focusing on a frontier area of biomedical science with vast potential for developing new personalized therapies and diagnostic tools. |
| MD667733 | New Drugs and Biologics Development | Directly enhances scientific research and innovation (Target 9.5) by focusing on the entire process of creating new pharmaceutical products for industry. |
SDG 17: Partnerships for the GoalsAlignment Summary: The international nature of this program and its focus on globally relevant health issues inherently foster partnerships. The curriculum requires engagement with the international scientific community through seminars and research dissemination, promoting the knowledge-sharing and multi-stakeholder collaborations vital for achieving global health goals.
| Course Code | Course Title | Alignment Rationale |
|---|---|---|
| MD667891 | Seminar in Pharmacology I | Promotes the global partnership for sustainable development (Target 17.6) by requiring students to engage with and present on the latest international research, fostering a culture of global knowledge-sharing. |
| MD66999X | Dissertation | Represents a significant contribution to global partnerships (Target 17.16) by creating new, publishable knowledge that is shared internationally to solve critical global health challenges. |